Showing 1 - 20 results of 85,376 for search '(( 1 treatment increases ) OR ((( b large decrease ) OR ( ((b marked) OR (a marked)) decrease ))))', query time: 1.68s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Withdrawal of Type I JAKinibs increased STAT phosphorylation, a phenomenon present but markedly lower in Type II JAKinibs. by Ilya Gurevic (1326786)

    Published 2025
    “…(A) pJAK2 peaked at time zero after exposure to baricitinib and ruxolitinib and then decreases. There was no increase in pJAK2 with CHZ868 treatment; (B) pSTAT1 proportion peaked after 60 minutes and was greater after Type I JAKinib withdrawal than Type II JAKinib withdrawal; <b>(C)</b> The pSTAT2 proportion peaked 60 minutes after Type I JAKinib withdrawal but this phenomenon was not seen with Type II JAKinib withdrawal.…”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Histology (<b>A</b>) of splenic immune architecture in response to <i>R</i>. <i>parkeri</i> infection and benidipine treatment (H&E stains; bars = 500 μm). by Andrés F. Londoño (6857828)

    Published 2024
    “…<i>parkeri</i> infection. With infection but no benidipine (f,i), the proportion of splenic volume occupied by white pulp and follicles decreased as a result of increasing red pulp (red arrows) volume and cellularity and fusion/fragmentation of follicles (white arrows). …”
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    ROC analysis to mark selectivity results in mostly mixed-selective units. by Thomas S. Wierda (22404198)

    Published 2025
    “…The large number of mixed selective units also results in a significant decrease in accuracy when these neurons are targeted as compared to <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013559#pcbi.1013559.g006" target="_blank">Fig 6c</a> where there was no significant effect visible after targeting mixed selective units, likely because there were less mixed selective units present. …”
  20. 20